方法对比
并排查看您选择的方法;存在差异的行会高亮显示。
| 鉴别性变异调用× | RNA-seq差异表达× | |
|---|---|---|
| 领域 | 生物信息学 | 生物信息学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2009–2013 (field matured with NGS; seminal tools 2009–2013) | 2008–2010 (RNA-seq DE methodology established) |
| 提出者≠ | Multiple groups; key tools: VarScan (Koboldt et al.), MuTect (Cibulskis et al.), GATK Haplotype Caller (DePristo et al.) | Multiple groups; foundational methods from Anders & Huber (DESeq, 2010), Robinson, McCarthy & Smyth (edgeR, 2010) |
| 类型≠ | Comparative genomic analysis pipeline | Quantitative genomics pipeline |
| 开创性文献≠ | Koboldt, D.C., Zhang, Q., Larson, D.E., Shen, D., McLellan, M.D., Lin, L., Miller, C.A., Mardis, E.R., Ding, L., & Wilson, R.K. (2012). VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Research, 22(3), 568–576. DOI ↗ | Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550. DOI ↗ |
| 别名 | somatic variant calling, comparative variant analysis, tumor-normal variant calling, differential SNV/indel calling | RNA-seq DE analysis, transcriptomic differential expression, bulk RNA-seq DE, DEA |
| 相关≠ | 2 | 6 |
| 摘要≠ | Differential variant calling is a bioinformatics pipeline that identifies genetic variants — single nucleotide variants (SNVs), small insertions/deletions (indels), and structural variants — that are present in one biological sample or condition but absent (or significantly enriched) in a paired reference sample. The canonical application is tumor-versus-normal cancer genomics, where somatic mutations unique to the tumor are distinguished from germline variants shared with normal tissue. The same logic applies to comparing treated vs. untreated cell lines, evolved vs. ancestral strains, or case vs. control cohorts in population genomics. | RNA-seq differential expression (DE) analysis identifies genes whose transcript abundance differs significantly between two or more biological conditions — for example, treated versus control, or diseased versus healthy tissue. Starting from raw sequencing reads, the pipeline moves through alignment, count-based normalization, statistical modeling of count dispersion, hypothesis testing, and multiple-testing correction to produce a ranked list of differentially expressed genes accompanied by fold-change estimates and adjusted p-values. |
| ScholarGate数据集 ↗ |
|
|